EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cutaneous vasculitis induced by dapagliflozin (forxiga): a rare adverse effect

Sandra Provenzano, Sandra Visioli, Valeria Ribattezzato, Maria Modugno

Italian Journal of Medicine · 06.11.2026 · 20 (4)

DOI: 10.4081/itjm.2026.2418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Italian Journal of Medicine, online erschienen am 06.11.2026. Verfasst von Sandra Provenzano und 3 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dear Editor,While common adverse events associated with sodium-glucose cotransporter-2 inhibitors, such as genitourinary infections and volume depletion, are well-characterized, rare immune-mediated cutaneous manifestations are increasingly recognized in post-marketing surveillance...

Zitieren

APA

Provenzano, S., Visioli, S., Ribattezzato, V., & Modugno, M. (2026). Cutaneous vasculitis induced by dapagliflozin (forxiga): a rare adverse effect. Italian Journal of Medicine, 20(4). https://doi.org/10.4081/itjm.2026.2418

Vancouver

Provenzano S, Visioli S, Ribattezzato V, Modugno M. Cutaneous vasculitis induced by dapagliflozin (forxiga): a rare adverse effect. Italian Journal of Medicine. 2026;20(4). doi:10.4081/itjm.2026.2418

BibTeX
@article{Provenzano2026,
  author = {Provenzano, Sandra and Visioli, Sandra and Ribattezzato, Valeria and Modugno, Maria},
  title = {Cutaneous vasculitis induced by dapagliflozin (forxiga): a rare adverse effect},
  journal = {Italian Journal of Medicine},
  year = {2026},
  volume = {20},
  number = {4},
  doi = {10.4081/itjm.2026.2418}
}
Kostenlos starten →